SC

Stempoint Capital Portfolio holdings

AUM $311M
1-Year Est. Return 15.22%
This Quarter Est. Return
1 Year Est. Return
+15.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$311M
AUM Growth
-$2.49M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1
+$13M
2
+$9.59M
3
+$9.03M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$8.83M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$8.55M

Top Sells

1
+$22.3M
2
+$11.3M
3
+$9.96M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$9.21M
5
CGON icon
CG Oncology
CGON
+$7.1M

Sector Composition

1 Healthcare 99.49%
2 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABUS icon
51
Arbutus Biopharma
ABUS
$845M
– –
-467,882
ASND icon
52
Ascendis Pharma
ASND
$12.7B
– –
-14,732
BBC icon
53
Virtus LifeSci Biotech Clinical Trials ETF
BBC
$19.6M
– –
0
BPMC
54
DELISTED
Blueprint Medicines
BPMC
– –
-61,927
CGON icon
55
CG Oncology
CGON
$3.16B
– –
-289,823
CVS icon
56
CVS Health
CVS
$105B
– –
0
CYTK icon
57
Cytokinetics
CYTK
$6.99B
– –
-149,648
DYN icon
58
Dyne Therapeutics
DYN
$2.33B
– –
-84,430
ELVN icon
59
Enliven Therapeutics
ELVN
$1.27B
– –
-120,430
EWTX icon
60
Edgewise Therapeutics
EWTX
$1.59B
– –
-180,255
FOLD icon
61
Amicus Therapeutics
FOLD
$2.48B
– –
-268,919
IFRX icon
62
InflaRx
IFRX
$79.9M
– –
-725,019
MRK icon
63
Merck
MRK
$212B
– –
0
NBIX icon
64
Neurocrine Biosciences
NBIX
$13.9B
– –
-21,052
NVO icon
65
Novo Nordisk
NVO
$242B
– –
0
OCUL icon
66
Ocular Therapeutix
OCUL
$2.51B
– –
-124,523
RVMD icon
67
Revolution Medicines
RVMD
$10.1B
– –
-318,782
SLDB icon
68
Solid Biosciences
SLDB
$458M
– –
-198,150
SLNO icon
69
Soleno Therapeutics
SLNO
$3.48B
– –
-11,155
SWTX
70
DELISTED
SpringWorks Therapeutics
SWTX
– –
-159,305
SYRE icon
71
Spyre Therapeutics
SYRE
$1.74B
– –
-136,139
XENE icon
72
Xenon Pharmaceuticals
XENE
$3.21B
– –
-274,633
BCAX
73
Bicara Therapeutics
BCAX
$997M
– –
-47,078
SION
74
Sionna Therapeutics
SION
$1.41B
– –
-60,000
1 2
3